Back to top of page

Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

List of required information for application:

1. Experimental therapeutics approach: Provide a detailed description of the experimental therapeutics approach that will be used for the development and testing of therapeutic interventions.

2. Clinical effect evaluation: Explain how the proposed study will evaluate the clinical effect of the intervention. Include information about the primary outcome measures and any secondary outcome measures that will be used.

3. Mechanisms underlying a disorder or intervention response: Describe how the study will generate information about the mechanisms underlying a disorder or an intervention response. Outline any specific measures or assessments that will be used to explore these mechanisms.

4. Pharmacologic interventions: If proposing pharmacologic interventions, provide information about their mechanisms of action and why they are considered novel. Include any preclinical data or evidence supporting the use of these interventions.

5. Device-based interventions: If proposing device-based interventions, explain how the devices work and why they are considered promising for the treatment of mental disorders. Provide any relevant preclinical or clinical data supporting the use of these interventions.

6. Protocol design: Outline the protocol design that will be used for the study. Explain how the presumed mechanism of action of the intervention will be adequately tested. Provide details about the study design, sample size, and any control or comparison groups that will be used.

7. Target modulation and dose-dependent effects: Describe how the study will assess target modulation and the dose-dependent neurophysiological, clinical, or behavioral effects of the intervention. Include information about the specific outcome measures that will be used to evaluate these effects.

8. Previous research: Provide a summary of any previous research or preliminary data that supports the feasibility of the proposed study. Include information about any prior studies with similar interventions or target mechanisms.

9. Timeline and milestones: Outline the timeline for the proposed study, including major milestones or deliverables. Describe how the study will progress from early stage testing to future phases of clinical trials or intervention development.

10. Budget: Provide a detailed budget for the proposed study, including information about personnel, equipment, supplies, and any other necessary expenses. Justify the requested budget based on the scope and objectives of the study.

11. Collaboration and partnerships: Describe any collaborations or partnerships that will be established for the proposed study. Include information about any research institutions, organizations, or industry partners that will be involved.

12. Ethical considerations: Discuss any ethical considerations that are relevant to the proposed study, such as participant recruitment, informed consent, and potential risks or benefits. Outline any measures that

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows